Member Info for wyndrum

Yes you are right Chris.

I was very disappointed on the day with the response to the science meet. It seemed to follow a pattern of these events.

Also, i thought you had agreed with me that this was ahigh risk stock?

Anyway, the move to a new 12 month high is very welcome and gives me more confidence to the chance of long term success.

"In other news, the share price is still perky, lovely job."

Oh, so now the SP (ie the market) isn't so thick today?

Or is it really the only thing/indicator that counts after all?

Fwiw Seadoc, I bought again today at 161.8 because I felt that was on a vague support and in any case would be within about 5% or so of a likely bottom and if it closed around the 155-162 area then that would unwind the RSI . At the moment it seems like a good move, but sometimes you just get lucky, but then again it can turn on a dime.

In smaller stocks (although this is a £1b mc), i only use the rsi and obvious support and resistance lines to try and time entry/exit.

I have found in aim stocks that Moving averages, volume, and other popular indicators are not reliable enough to base my decisions on.

Its very easy to get whipsawed with fast moving stocks and TA generally is more reliable on indices then individual stocks because they have small spreads, huge volume and liquidity.

Some stocks meet some of the criteria but ultimately are so small that they can be easily manipulated. (When I was training in futures they advised to stay away from the ftse 100 as an example, as it was too small and could be deliberately moved.) so it was bond futures for me.

Anyway. this one looks good for the near future!

atb

"The LFT inadvertently funded the cancer platform because of the rise in SP. They took full advantage but that chapter is firmly in the past. LFT BS…. I’m not even reading Windy and that’s all he can come up with, it’s ridiculous!!!"

No it didn't the vast majority went on the lft, then the other one went on the diagnostic co's.

And now ice admits that nmany great companies have problems and duds along the way.

What do you think I have been saying!

In the meantime I don;t suppose ice has the figures for companies that thought uyp duds that actually went bust.

This is all hindsight stuff simply because AVCT is still in the game.

I am not sure where they would be had RH not come in and resolved the heights repayment scheme. Ar you?

Yes, why do you bother Alderbaron?

It makes no odds to you

This is a BB to exchange views. Yyour lop sided view of history is quite remarkable.

Its like you and others have always seen AVCt as a straight forward growth company delivering positive results every quarter with no set backs or any problems.

Its like you knew when AS said P1 would take 2 years you knew he meant 5/6. Its like you knew he would do the fund raises when he did and buy diagnostic companies? its like you knew RH was going to come on board and change the financial structure of the company, its like you knew he was going to get sacked and CC come in.

And of course I can't mention the LFT because that was such a disaster it simply is no longer in AVCT's history (although the way some go on at me about it as though they knew all along it was doomed too.)

Yes BV, I am a bit odd that way:

When i think the news is good I will buy and when I think the news is poor I will sell. But thats just me.

I don't have the skill to be able to forecast trial results before the trial has started. However I am in better company there though, nor does the FDA it seems

"We've had no market moving news since those comments but slowly the market is cottoning on to the risk/reward here and catching up. "

Except we have.

I am saying the market based on the latest science day and reiteration from CC is adjusting its risk reward as am i. (The new news was that there was no bad news)

Its still remains to be seen/confirmed what the results will show.

"And there's no more sitting on the sidelines and waiting without fully missing out."

What does that mean, exactly? what does the SP have to be before you think that statement applies?

God, you all do work so hard to try and the merest crack in my arguments.

Regarding the RSI I use to time entry and exit.

Today at opening the RSI was 62.9. Now, given it had actually broken the resistance it was not actually the riskiest place to buy.

I tend to look to sell when it (RSI) hits 80 plus.

I also think (but what do i know), that the 80-82p level was so tough to break that as the RSI rises now it will start to move into overbought territory and I would not be surprised for it to fall back to that level in the absence of new news, which in turn would/could be a great place to top up/buy.

But then again because I rarely am negative about AVCt it does somewhat undermine all your subsequent posts.

Timster I have been very clear that the "platform" works,

Its outcomes that I have queried and that those 2 things are separate.

The fact you refuse to understand whats in front of you is either deliberate just so you can do your boring stchik or you simply can't read.

Well not really safe, my reticence was borne out of my belief that ava6k was problematic with outcomes.

Everyone here not unreasonably but still imo flawed was the assumption that ipso facto the outcomes HAD to be better and I don;t think the data was conclusive enough particularly with such a relatively small patient sample to justify that.

Now, with more time and more tweaking and this new trial combined with CC's ever increasing optimism that the market isprepared to expect good/great results and are strting to get on board.

I think the other false assumption many here have is that the market does not understand bio tech. Again the mkt cap of AVCt has quite a lot of positives already built in, ie the platform works and even if for the sake of argument, avct in their trials don't crack it, the platform in someone elses hands may well succeed with better outcomes.

I am cautious in putting too much faith in rhetoric as historically in my reasonably broad experience of over half a century as it is easy to get carried away by what they say and then the reality of what they deliver. (hence why I eventually turned to trading to take advantage where i could of ride the wave of optimism and not caught in the draw of disappointment.

Morning Stuart, my experience is that "bad" news is simply ignored.

We won the design win. great. The expectation was it would go into production, the key word "expectation". If it didn't (as i believe), then what is there to say? by ignoring it they simply side step that. Why make a statement about it? it can only be seen negatively.

To sell anything, you just tell the buyer what they want to hear. Honesty is sometimes a by product, but not always.

Great to hear!

give her my best. (and tell her it gets easier and easier!)

My take would be that the market has known for a long time that the platform works and i think this separation is critical when being perplexed at the market reaction (almost daily) to AVCt and its valuation.

The platform is designed to reduce dramatically the toxicity of anti cancer drugs and only releasing them at the tumour.

The second part that seems an obvious conclusion is therefore it will be more effective at the tumour. Its this part that I think has been mor opaque and therefore the market broadly agrees with us on this board in its conclusion but the data from ava6k was enough to give some encouragement but not conclusive, or at least was less than the market expected.

That has been the "problem" with the SP. (also the poor financial structure of the company previously was a severe constraint on SP stability let alone appreciation).

Over the last 6 months AVCt have given financial stability to the company.

Scientifically, there has been rapid progress in getting the latest trial into patients. CC is being more and more confident in her interviews so imo, the market had already factored into the Sp, the "working" platform, but now they are begining to factor in the improved expected outcomes to patients from this platform.

Once they are convinced this is the case then it does open up the prospect of the "platform" working with a myriad of drugs present and new.

The data coming out very soon is obviously key to this objective.

The market listens (imo) very closely to what CC says, now they expect the data to back this up.

if it does, and it sounds like it will then the rerate should come pretty quickly.

Ha ha, good old AVCT!

it feels we are pretty close hear now, I think 2.p is going to feel significant.

Hows no.2 daughter doing with the guitar?

The thing is Seadoc, that on a strong upward trend a small retrace has a disproportionate effect on reducing the RSI, that gets compounded with whatever the spread is too.

(But I do agree the RSI is the key indicator to pay attention to.) Cheers

Clearly, the design win did not make it to production. Maybe it was good idea but not reliable, or too expensive who knows but its been dead since october.

Morning D,

did your meet with other lse members put to bed you and me are not the same? (and also were they (and I imagine they were) somewhat more socially amenable?

Ah, hindsight... what it is to be blessed with it....

Its about Yeboa, you making a baseless call which I obviously knew was just an enthusiastic ramp which suggests an "agenda" (ha ha) And we all know that is a no-no, don't we?

But had somebody made just as baseless call for a fall there would have been insults galore and a very unpolite message to stop posting and go away.

So to spell it out for you it was to highlight the double standards you and others employ.

"My prediction is we end in the 90s today ! might be a late move but we will !"

I understand now Yeboa, why you did not want o divulge your "system".